Disc Medicine, Inc. SEC filings IRON
Disc Medicine, Inc. has 778 filings in SEC EDGAR's recent list, going back to Jul 2, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Nov 5, 2026 | — |
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Oct 22, 2026 | Oct 19, 2026 |
| 424B5 | Prospectus supplement | Oct 21, 2026 | — |
| 424B5 | Prospectus supplement | Oct 20, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 19, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 10, 2026 | Sep 9, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 30, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 18, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2026 | — |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Exit or restructuring costs
|
Feb 27, 2026 | Feb 26, 2026 |
| S-8 | Employee stock plan registration | Feb 26, 2026 | — |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 17, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 7, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 22, 2025 | Oct 20, 2025 |
| 424B5 | Prospectus supplement | Oct 21, 2025 | — |
| 424B5 | Prospectus supplement | Oct 20, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Other events
|
Oct 17, 2025 | Oct 16, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 6, 2025 | Oct 3, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 14, 2025 | Jul 9, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 11, 2025 |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| ARS | Annual report to shareholders | Apr 24, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 24, 2025 | — |
| DEF 14A | Proxy statement | Apr 24, 2025 | Jun 11, 2025 |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 24, 2025 | Jan 21, 2025 |
| 424B5 | Prospectus supplement | Jan 23, 2025 | — |
| 424B5 | Prospectus supplement | Jan 21, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 9, 2024 | Dec 8, 2024 |
| EFFECT | Filing | Nov 19, 2024 | — |
| 424B5 | Prospectus supplement | Nov 15, 2024 | — |
| POS AM | Filing | Nov 15, 2024 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Nov 15, 2024 | Nov 15, 2024 |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Nov 8, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 4, 2024 | Nov 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 25, 2024 | Oct 25, 2024 |
| S-3ASR | Automatic shelf registration | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 12, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 424B5 | Prospectus supplement | Jun 14, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | May 1, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | May 1, 2024 | Jun 12, 2024 |
| DEFA14A | Additional proxy material | May 1, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 2, 2024 | Apr 1, 2024 |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2023 | Dec 11, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| EFFECT | Filing | Dec 6, 2023 | — |
| 8-K |
Current report
Material agreement
|
Dec 5, 2023 | Dec 5, 2023 |
| POS AM | Filing | Dec 5, 2023 | — |
| 424B5 | Prospectus supplement | Dec 5, 2023 | — |
| EFFECT | Filing | Nov 29, 2023 | — |
| CORRESP | Letter to the SEC | Nov 27, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2023 | — |
| S-3 | Shelf registration | Nov 20, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Officer or director change
|
Oct 23, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Material agreement
|
Oct 10, 2023 | Oct 10, 2023 |
| 424B5 | Prospectus supplement | Oct 10, 2023 | — |
| 8-K |
Current report
Agreement ended
|
Sep 29, 2023 | Sep 28, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 16, 2023 | Jun 12, 2023 |
| 424B5 | Prospectus supplement | Jun 15, 2023 | — |
| 8-K |
Current report
Other events
|
Jun 12, 2023 | Jun 12, 2023 |
| 424B5 | Prospectus supplement | Jun 12, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 9, 2023 | Jun 9, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| ARS | Annual report to shareholders | Apr 20, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 20, 2023 | — |
| DEF 14A | Proxy statement | Apr 20, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 19, 2023 | Apr 18, 2023 |
| 10-K | Annual report | Mar 31, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2023 | Mar 31, 2023 |
| 424B5 | Prospectus supplement | Feb 14, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 14, 2023 | Feb 13, 2023 |
| 8-K |
Current report
Material agreement
|
Jan 25, 2023 | Jan 25, 2023 |
| 424B5 | Prospectus supplement | Jan 25, 2023 | — |
| EFFECT | Filing | Jan 24, 2023 | — |
| EFFECT | Filing | Jan 24, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jan 23, 2023 | Jan 19, 2023 |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| CORRESP | Letter to the SEC | Jan 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 19, 2023 | — |
| S-3 | Shelf registration | Jan 18, 2023 | — |
| S-8 | Employee stock plan registration | Jan 18, 2023 | — |
| S-3 | Shelf registration | Jan 18, 2023 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Dec 29, 2022 | Dec 29, 2022 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 28, 2022 | Dec 28, 2022 |
| 425 | Filing | Dec 27, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 27, 2022 | Dec 27, 2022 |
| 425 | Filing | Dec 13, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 13, 2022 | Dec 11, 2022 |
| 425 | Filing | Dec 8, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Dec 8, 2022 | Dec 2, 2022 |
| SEC STAFF LETTER | Filing | Dec 2, 2022 | — |
| EFFECT | Filing | Dec 2, 2022 | — |
| 424B3 | Prospectus | Dec 2, 2022 | — |
| CORRESP | Letter to the SEC | Dec 1, 2022 | — |
| S-4/A | Filing | Dec 1, 2022 | — |
| CORRESP | Letter to the SEC | Dec 1, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 29, 2022 | — |
| CORRESP | Letter to the SEC | Nov 23, 2022 | — |
| S-4/A | Filing | Nov 23, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 17, 2022 | — |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| S-4/A | Form s-4/a | Nov 3, 2022 | — |
| CORRESP | Letter to the SEC | Nov 2, 2022 | — |
| 425 | Filing | Oct 31, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 31, 2022 | Oct 31, 2022 |
| SEC STAFF LETTER | Filing | Oct 28, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 27, 2022 | — |
| S-4/A | Filing | Oct 7, 2022 | — |
| CORRESP | Letter to the SEC | Oct 7, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 3, 2022 | — |
| S-4 | Registration for a merger or exchange | Sep 2, 2022 | — |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 425 | Filing | Aug 10, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 10, 2022 | Aug 9, 2022 |
| 425 | Filing | Aug 10, 2022 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 10, 2022 | Aug 9, 2022 |
| 10-Q | Quarterly report | May 6, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 5, 2022 | Apr 5, 2022 |
| EFFECT | Filing | Mar 14, 2022 | — |
| POS AM | Filing | Mar 11, 2022 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| POS AM | Filing | Mar 10, 2022 | — |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 424B3 | Prospectus | Feb 28, 2022 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Feb 28, 2022 | Feb 28, 2022 |
| 424B3 | Prospectus | Jan 14, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2022 | Jan 13, 2022 |
| 424B3 | Prospectus | Jan 10, 2022 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 10, 2022 | Jan 10, 2022 |
| 424B3 | Prospectus | Nov 15, 2021 | — |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 12, 2021 | Nov 12, 2021 |
| S-8 | Employee stock plan registration | Oct 14, 2021 | — |
| 424B3 | Prospectus | Oct 6, 2021 | — |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Oct 6, 2021 | Oct 4, 2021 |
| 424B3 | Prospectus | Oct 1, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 1, 2021 | Sep 29, 2021 |
| 424B3 | Prospectus | Sep 9, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Sep 9, 2021 | Sep 7, 2021 |
| DEFA14A | Additional proxy material | Aug 17, 2021 | — |
| DEF 14A | Proxy statement | Aug 17, 2021 | Sep 29, 2021 |
| 424B3 | Prospectus | Aug 17, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Aug 17, 2021 | Aug 16, 2021 |
| 424B3 | Prospectus | Aug 12, 2021 | — |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 424B3 | Prospectus | Jun 23, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 23, 2021 | Jun 22, 2021 |
| 424B3 | Prospectus | May 13, 2021 | — |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| 424B3 | Prospectus | May 12, 2021 | — |
| 8-K |
Current report
Officer or director change
|
May 7, 2021 | May 3, 2021 |
| EFFECT | Filing | Apr 28, 2021 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IRON (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Watertown, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1816736
- Former names
- Gemini Therapeutics, Inc. /DE (until Dec 28, 2022); FS Development Corp. (until Feb 8, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.